These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14641072)

  • 1. Anti-AGEing defences against Alzheimer's disease.
    Münch G; Kuhla B; Lüth HJ; Arendt T; Robinson SR
    Biochem Soc Trans; 2003 Dec; 31(Pt 6):1397-9. PubMed ID: 14641072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations on oxidative stress and therapeutical implications in dementia.
    Durany N; Münch G; Michel T; Riederer P
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 3():68-73. PubMed ID: 10654103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation endproducts and pro-inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology.
    Münch G; Apelt J; Rosemarie-Kientsch-Engel ; Stahl P; Lüth HJ; Schliebs R
    J Neurochem; 2003 Jul; 86(2):283-9. PubMed ID: 12871569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease.
    Wong A; Lüth HJ; Deuther-Conrad W; Dukic-Stefanovic S; Gasic-Milenkovic J; Arendt T; Münch G
    Brain Res; 2001 Nov; 920(1-2):32-40. PubMed ID: 11716809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the Glyoxalase System in Alzheimer's Disease.
    Jiang L; Wang J; Wang Z; Huang W; Yang Y; Cai Z; Li K
    J Alzheimers Dis; 2018; 66(3):887-899. PubMed ID: 30400091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation endproducts in ageing and Alzheimer's disease.
    Münch G; Thome J; Foley P; Schinzel R; Riederer P
    Brain Res Brain Res Rev; 1997 Feb; 23(1-2):134-43. PubMed ID: 9063589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease.
    Kuhla B; Lüth HJ; Haferburg D; Boeck K; Arendt T; Münch G
    Ann N Y Acad Sci; 2005 Jun; 1043():211-6. PubMed ID: 16037241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on tau aggregation and filament formation.
    Kuhla B; Haase C; Flach K; Lüth HJ; Arendt T; Münch G
    J Biol Chem; 2007 Mar; 282(10):6984-91. PubMed ID: 17082178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.
    Takeuchi M; Yamagishi S
    Curr Pharm Des; 2008; 14(10):973-8. PubMed ID: 18473848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?
    Dukic-Stefanovic S; Schinzel R; Riederer P; Münch G
    Biogerontology; 2001; 2(1):19-34. PubMed ID: 11708614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Inflammatory Pathways in Alzheimer's Disease: A Focus on Natural Products and Phytomedicines.
    Sharman MJ; Verdile G; Kirubakaran S; Parenti C; Singh A; Watt G; Karl T; Chang D; Li CG; Münch G
    CNS Drugs; 2019 May; 33(5):457-480. PubMed ID: 30900203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of glyoxalase enzyme activity precludes cognitive dysfunction in a mouse model of Alzheimer's disease.
    More SS; Vartak AP; Vince R
    ACS Chem Neurosci; 2013 Feb; 4(2):330-8. PubMed ID: 23421684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunochemical study on tau glycation in paired helical filaments.
    Ko LW; Ko EC; Nacharaju P; Liu WK; Chang E; Kenessey A; Yen SH
    Brain Res; 1999 Jun; 830(2):301-13. PubMed ID: 10366687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end products as biomarkers and gerontotoxins - A basis to explore methylglyoxal-lowering agents for Alzheimer's disease?
    Krautwald M; Münch G
    Exp Gerontol; 2010 Oct; 45(10):744-51. PubMed ID: 20211718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of methylglyoxal in Alzheimer's disease.
    Angeloni C; Zambonin L; Hrelia S
    Biomed Res Int; 2014; 2014():238485. PubMed ID: 24734229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains.
    Kuhla B; Boeck K; Schmidt A; Ogunlade V; Arendt T; Münch G; Lüth HJ
    Neurobiol Aging; 2007 Jan; 28(1):29-41. PubMed ID: 16427160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoxidative stress creates a vicious cycle of neurodegeneration in Alzheimer's disease--a target for neuroprotective treatment strategies?
    Münch G; Deuther-Conrad W; Gasic-Milenkovic J
    J Neural Transm Suppl; 2002; (62):303-7. PubMed ID: 12456073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia.
    Wong A; Dukic-Stefanovic S; Gasic-Milenkovic J; Schinzel R; Wiesinger H; Riederer P; Münch G
    Eur J Neurosci; 2001 Dec; 14(12):1961-7. PubMed ID: 11860491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease.
    Rahmadi A; Steiner N; Münch G
    Clin Chem Lab Med; 2011 Mar; 49(3):385-91. PubMed ID: 21275816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.